مغاير
مراجع

↑  Medical dictionary نسخة محفوظة 2021-04-19 على موقع واي باك مشين.
↑  Merriam-Webster Dictionary نسخة محفوظة 2021-09-18 على موقع واي باك مشين.
↑  "Heterogeneity and complexity of native brain nicotinic receptors". Biochemical Pharmacology  ‏. ج. 74 ع. 8: 1102–11. أكتوبر 2007. DOI:10.1016/j.bcp.2007.05.023. PMID:17597586.{{استشهاد بدورية محكمة}}:  صيانة الاستشهاد: علامات ترقيم زائدة (link)
↑  "Diversity of vertebrate nicotinic acetylcholine receptors". Neuropharmacology. ج. 56 ع. 1: 237–46. يناير 2009. DOI:10.1016/j.neuropharm.2008.07.041. PMID:18723036. مؤرشف من الأصل في 2021-12-20.
↑  Collins AC، Salminen O، Marks MJ، Whiteaker P، Grady SR (2009). "The road to discovery of neuronal nicotinic cholinergic receptor subtypes". Nicotine Psychopharmacology. Handbook of Experimental Pharmacology. ج. 192. ص. 85–112. DOI:10.1007/978-3-540-69248-5_4. ISBN:978-3-540-69246-1. PMC:8759235. PMID:19184647.
↑  "Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders". Current Drug Targets. CNS and Neurological Disorders. ج. 1 ع. 4: 387–97. أغسطس 2002. DOI:10.2174/1568007023339283. PMID:12769611.
↑  Nutt D (أبريل 2006). "GABAA receptors: subtypes, regional distribution, and function". Journal of Clinical Sleep Medicine. ج. 2 ع. 2: S7–11. DOI:10.5664/jcsm.26525. PMID:17557501.
↑  "Forebrain and midbrain distribution of major benzodiazepine–sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization". Neuroscience. ج. 150 ع. 2: 370–85. ديسمبر 2007. DOI:10.1016/j.neuroscience.2007.09.008. PMC:2292345. PMID:17950542.
↑  "Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers". Journal of Neuroscience. ج. 26 ع. 7: 2080–7. فبراير 2006. DOI:10.1523/JNEUROSCI.3574-05.2006. PMC:6674939. PMID:16481441.
↑  "Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain". Frontiers in Bioscience. ج. 13 ع. 13: 2391–9. 2008. DOI:10.2741/2852. PMID:17981720. مؤرشف من الأصل في 2023-03-06.
↑  "D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum". Proceedings of the National Academy of Sciences of the United States of America. ج. 104 ع. 2: 654–9. يناير 2007. Bibcode:2007PNAS..104..654R. DOI:10.1073/pnas.0604049104. PMC:1766439. PMID:17194762.
↑  "Identification of Dopamine D1–D3 Receptor Heteromers: INDICATIONS FOR A ROLE OF SYNERGISTIC D1–D3 RECEPTOR INTERACTIONS IN THE STRIATUM". The Journal of Biological Chemistry. ج. 283 ع. 38: 26016–25. سبتمبر 2008. DOI:10.1074/jbc.M710349200. PMC:2533781. PMID:18644790.{{استشهاد بدورية محكمة}}:  صيانة الاستشهاد: دوي مجاني غير معلم (link)
↑  "Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids". Neuropsychopharmacology. ج. 32 ع. 11: 2249–59. 2007. DOI:10.1038/sj.npp.1301375. PMID:17356572.
↑  "The A2A-adenosine receptor: a GPCR with unique features?". British Journal of Pharmacology. 153 Suppl 1 ع. S1: S184–90. مارس 2008. DOI:10.1038/sj.bjp.0707674. PMC:2268059. PMID:18246094.
↑  "Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis". Neuropharmacology. ج. 54 ع. 5: 815–23. أبريل 2008. DOI:10.1016/j.neuropharm.2007.12.011. PMID:18262573.
↑  "Detection of heteromerization of more than two proteins by sequential BRET-FRET". Nature Methods. ج. 5 ع. 8: 727–33. 2008. DOI:10.1038/nmeth.1229. PMID:18587404.
↑  "Looking for the role of cannabinoid receptor heteromers in striatal function". Neuropharmacology. 56 Suppl 1 ع. Suppl 1: 226–34. 2009. DOI:10.1016/j.neuropharm.2008.06.076. PMC:2635338. PMID:18691604.
↑  "G-protein-coupled receptor heteromers: function and ligand pharmacology". British Journal of Pharmacology. 153 Suppl 1 ع. S1: S90–8. مارس 2008. DOI:10.1038/sj.bjp.0707571. PMC:2268068. PMID:18037920.
↑  "Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology". Brain Research Reviews. ج. 58 ع. 2: 415–52. أغسطس 2008. DOI:10.1016/j.brainresrev.2007.11.007. PMID:18222544.
↑  "Novel pharmacological targets based on receptor heteromers". Brain Research Reviews. ج. 58 ع. 2: 475–82. أغسطس 2008. DOI:10.1016/j.brainresrev.2008.06.002. PMID:18620000.
↑  "Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia". Journal of Neural Transmission. ج. 116 ع. 8: 923–39. يناير 2009. DOI:10.1007/s00702-008-0174-9. PMC:2953764. PMID:19156349.
↑  "Building a new conceptual framework for receptor heteromers". Nature Chemical Biology. ج. 5 ع. 3: 131–4. مارس 2009. DOI:10.1038/nchembio0309-131. PMC:2681085. PMID:19219011.
بوابة طب
بوابة علم الأحياء الخلوي والجزيئي